1. Alexion says “no” to investor proactive sale demand — FDA approves first copycats of Novartis MS drug Gilenya — $178M stockpile of Merck ebola vaccine authorized — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Jobs & Business Opportunities - Northeast


Sort By:
Title
Replies Views
Last Message ↓
  1. CP Staff
    Replies:
    0
    Views:
    236
  2. CP Staff
    Replies:
    0
    Views:
    129

Thread Display Options

Loading...